Phase I factorial study of temozolomide plus memantine, mefloquine, and metformin as post-radiation adjuvant therapy for newly diagnosed glioblastoma.

被引：0
|
作者：
Maraka, Stefania
Groves, Morris D.
Mammoser, Aaron Gerald
Melguizo-Gavilanes, Isaac
Conrad, Charles A.
Tremont-Lukats, Ivo
Loghin, Monica Elena
O'Brien, Barbara Jane
Puduvalli, Vinay K.
Sulman, Erik P.
Hess, Kenneth R.
Aldape, Kenneth D.
Gilbert, Mark R.
De Groot, John Frederick
Yung, W. K. Alfred
Penas-Prado, Marta
机构：
[1] Univ Texas MD Anderson Canc Ctr, Neurooncol Dept, Houston, TX USA
[2] LSU Hlth Sci Ctr, Dept Neurosurg, New Orleans, LA USA
[3] Aurora Canc Care Neurooncol, Milwaukee, WI USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Houston Methodist Hosp, Neurooncol, Neurol, Houston, TX USA
[6] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[7] Natl Canc Inst, Ctr Canc Res, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2044
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2044
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PHASE II STUDY OF HYPOFRACTIONATED RADIATION THERAPY WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE FOLLOWING SURGICAL RESECTION FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: PRELIMINARY EVALUATION
    Navarria, P.
    Pessina, F.
    Ascolese, A.
    Tomatis, S.
    Bello, L.
    Simonelli, M.
    Riva, M.
    Lopci, E.
    Santoro, A.
    Scorsetti, M.
    NEURO-ONCOLOGY, 2016, 18 : 51 - 51
  • [42] EF-32 (TRIDENT): A pivotal randomized trial of radiation therapy concomitant with temozolomide plus /- Tumor Treating Fields (TTFields) in newly diagnosed glioblastoma.
    Shi, Wenyin
    Kleinberg, Lawrence
    Jeyapalan, Suriya A.
    Goldlust, Samuel A.
    Nagpal, Seema
    Combs, Stephanie E.
    Roberge, David
    Nishigawa, Ryo
    Grossman, Rachel
    Glas, Martin
    CANCER RESEARCH, 2021, 81 (13)
  • [43] A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma
    Huang, Jiayi
    Campian, Jian L.
    Dewees, Todd A.
    Skrott, Zdenek
    Mistrik, Martin
    Johanns, Tanner M.
    Ansstas, George
    Butt, Omar
    Leuthardt, Eric
    Dunn, Gavin P.
    Zipfel, Gregory J.
    Osbun, Joshua W.
    Abraham, Christopher
    Badiyan, Shahed
    Schwetye, Katherine
    Cairncross, J. Gregory
    Rubin, Joshua B.
    Kim, Albert H.
    Chheda, Milan G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (03): : 738 - 749
  • [44] Phase 3 TRIDENT trial: Radiation and temozolomide plus /- Tumor Treating Fields in newly diagnosed glioblastoma
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S72 - S72
  • [45] A PHASE I TRIAL OF PEMBROLIZUMAB AND VORINOSTAT COMBINED WITH TEMOZOLOMIDE AND RADIATION THERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA (NCT03426891)
    Sahebjam, Solmaz
    Forsyth, Peter
    Nam Tran
    Mokhtari, Sepideh
    Arrington, John
    Jaglal, Michael
    Etame, Arnold
    Liu, James
    Wicklund, Melissa
    Gatewood, Tyra
    Macaulay, Robert
    Robinson, Timothy
    Yu, Michael
    NEURO-ONCOLOGY, 2018, 20 : 2 - 2
  • [46] PHASE I TRIAL OF DIMETHYL FUMARATE, TEMOZOLOMIDE AND RADIATION THERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME: A PRELIMINARY NEUROCOGNITIVE PERSPECTIVE
    Loughan, Ashlee
    Shafer, Danielle
    Lanoye, Autumn
    Braun, Sarah
    Dent, Paul
    Malkin, Mark
    NEURO-ONCOLOGY, 2017, 19 : 141 - 142
  • [47] A Phase II Trial of Concurrent Sunitinib, Temozolomide and Radiation Therapy Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients with an Unmethylated MGMT Gene Promoter
    Faye, M. D.
    Sabri, S.
    De Robles, P.
    Agnihotram, R.
    Torres-Vasquez, A.
    Panet-Raymond, V.
    Shenouda, G.
    Souhami, L.
    Esaw, J.
    Abdulkarim, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S169 - S169
  • [48] A COMBINED ANALYSIS OF TWO RANDOMISED STUDIES EXPLORING THE IMPACT OF EXTENDED POST-RADIATION TEMOZOLOMIDE ON SURVIVAL OUTCOMES IN NEWLY DIAGNOSED GLIOBLASTOMA
    Gately, Lucy
    Mesia, Carlos
    Sepulveda, Juan
    del Barco, Sonia
    Pineda, Estela
    Girones, Regina
    Fuster, Jose
    Hong, Wei
    Gill, Sanjeev
    Miguel Navarro, Luis
    Herrero, Ana
    Dowling, Anthony
    De La Penas, Ramon
    Angeles Vaz, Maria
    Alonso, Miriam
    Lwin, Zarnie
    Harrup, Rosemary
    Peralta, Sergio
    Long, Anne
    Perez-Segura, Pedro
    Ahern, Elizabeth
    Olier Garate, Clara
    Wong, Mark
    Campbell, Robert
    Cuff, Katharine
    Jennens, Ross
    Gallego, Oscar
    Underhill, Craig
    Martinez-Garcia, Maria
    Covela, Marta
    Cooper, Adam
    Brown, Stephen
    Rosenthal, Mark
    Torres, Javier
    Collins, Ian M.
    Gibbs, Peter
    Balana, Carmen
    NEURO-ONCOLOGY, 2023, 25
  • [49] Phase 2 Trial of Hypofractionated High-Dose Intensity Modulated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
    Iuchi, Toshihiko
    Hatano, Kazuo
    Kodama, Takashi
    Sakaida, Tsukasa
    Yokoi, Sana
    Kawasaki, Koichiro
    Hasegawa, Yuzo
    Hara, Ryusuke
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (04): : 793 - 800
  • [50] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy post-operatively in patients with newly diagnosed glioblastoma multiforme
    Pecreboom, DM
    Brewer, C
    Stevens, GHJ
    Suh, JH
    Toms, S
    Vogelbaum, MA
    Barnett, GH
    NEURO-ONCOLOGY, 2004, 6 (04) : 379 - 379
12345